Groupe d'Etude en Oncologie du Quebec

Title	Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women
Protocole ID	A10-M84-07A
ClinicalTrials.gov ID	NCT02296307
Cancer Type(s)	Ovary
Phase	Other
Stage
Study Type	Diagnostic
Drug
Institution	CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN 1001 boul. Décarie , Montréal, QC, H4A 3J1
City	Montréal
Principal Investigator	Dr. Lucy Gilbert
Coordinator	Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975
Status	Recruiting
Activation Date
Eligibility Criteria	Sign an approved informed consent form (ICF). Be ≥ 50 years of age. Have at least one symptom outlined in below for a period of ≥2 weeks but ≤ 1 year: Feeling full after eating only a few bites, loss of appetite Diarrhoea, constipation, bowel or rectum feels full, change in bowel habits, constant urge to have a bowel movement, painful or burning bowel movements, rectal pain, painful defecation Bloating, distension of abdomen, clothes around the waist feel too tight, feel an abdominal mass Weight loss not because of dieting Nausea, vomiting, heartburn, gas, burping, indigestion Increased urinary frequency, need to urinate urgently, pressure on the bladder, leaking urine, burning sensation when urinating, need to urinate but unable to do so, unable to empty bladder completely, feeling full after urinating Vaginal discharge, bleeding, spotting, deep pain on intercourse Discomfort or pain in abdomen, or pelvic region, or lower back Subjects must be willing to comply with study protocol
Exclusion Criteria	Previous bilateral salpingo-oophorectomy (BSO) Previous diagnosis of cancer in the ovaries, fallopian tubes, or peritoneum Current bleeding per rectum, not due to haemorrhoids Current frank haematuria Symptoms that suggest the need for urgent clinical evaluation outside of a research protocol

Groupe d'étude en oncologie du Québec